Portuguese 
Spanish 
Million-dollar investment, sanitary interdictions, and microbiological risk place Ypê at the center of one of the largest recent crises in the cleaning industry in Brazil. While the company promises to modernize the Amparo factory with standards equivalent to those of the pharmaceutical industry, Anvisa maintains restrictions and increases pressure on the manufacturer.
Under pressure from the sanitary restrictions imposed by Anvisa, Ypê reported that it intends to invest around R$ 130 million in restructuring the Amparo factory, in the interior of São Paulo, after successive citations related to the risk of microbiological contamination in cleaning products.
The decision of the regulatory agency gained strength after the determination published on May 7, 2026, which suspended the manufacturing, commercialization, distribution, and use of batches with final number 1 of dishwashing liquids, liquid soaps, and disinfectants manufactured by the company.
Ypê’s plan includes construction and a microbiology laboratory
In response to the requirements imposed by the sanitary authorities, the company reformulated the adaptation plan for the Amparo unit after the inspection carried out between April 27 and 30, 2026, with the participation of Anvisa, CVS-SP, and the municipal surveillance.
-
At 14 years old, she worked in a factory in Hong Kong, studied economics abroad, and then entered the Chinese real estate market, which helped change the landscape of Beijing.
-
While NATO secured more than $10 billion in missiles and space surveillance at a single forum, Brazil still spends 1.1% of its GDP on defense and is stalling its own anti-aircraft system.
-
Corn ethanol attracts R$ 23 billion in 21 new plants and prepares for a nearly 50% jump in Brazilian production by 2027, even with high interest rates.
-
A newly opened terminal in the middle of the Amazon has begun transporting soy and corn through Amapá, eyeing the queue of ships that is congesting the ports in the South.
Initially, the manufacturer estimated spending between R$ 100 million and R$ 110 million over 12 months, but the forecast was increased to approximately R$ 130 million after new operational failures were pointed out during the inspection.
Among the measures planned by the company are changes in sanitization protocols, reinforcement of the water treatment system, and the installation of a microbiology laboratory described by the manufacturer itself as equipped with “pharmaceutical-level” technology.
In an interview with Folha, Ypê’s legal and corporate affairs director, Sergio Pompilio, stated that the adaptation program has been reviewed in recent weeks and highlighted that there is “a very strong focus on water treatment.”
Anvisa points out sanitary risk and manufacturing failures
According to Anvisa, the decision was made after technical evaluations identified significant non-compliance in critical stages of production, including failures related to quality assurance, manufacturing processes, and internal control of the unit.
In the evaluation of the regulatory agency, the problems compromise essential requirements of Good Manufacturing Practices for sanitizers and increase the risk of microbiological contamination, with the possible presence of pathogenic microorganisms in products intended for consumers.
Even after the company’s appeal, which temporarily suspended the resolution, Anvisa maintained the guidance for consumers not to use the products affected by the measure, for safety reasons.
On May 15, 2026, the Board of Directors of Anvisa decided to maintain the suspension of the manufacturing, distribution, and sale of the affected batches, according to Agência Brasil.
History of interdictions increases pressure on factory in Amparo
The vote of Anvisa’s director-president, Leandro Pinheiro Safatle, noted that the most recent inspection was prompted by a history of non-conformities related to the microbiological quality of products from Química Amparo, manufacturer of Ypê.
The document cites previous sanitary measures, including a 2024 resolution that affected 361 batches and a 2025 decision prompted by the detection of the bacterium Pseudomonas aeruginosa in analyses conducted by the manufacturer itself.
Anvisa also recorded that the May 2026 measure again involved possible microbiological contamination by Pseudomonas aeruginosa, in addition to non-compliance with Good Manufacturing Practices standards for cleaning products.
Company contests Anvisa’s precautionary measures
In statements sent to the public authorities, Ypê argued that the adjustment plan aims to raise industrial control standards and stated that a significant part of the planned actions had already been implemented before the most recent precautionary measures.
Furthermore, the manufacturer claimed, as recorded in Anvisa’s vote, that products blocked internally had not been distributed to the market and contested the interpretation that there was an imminent risk to consumer health.
Despite these arguments, the agency concluded that the situation went beyond a one-off episode and reflected a set of technical evidence related to persistent failures in manufacturing process controls.
Complaint involving Unilever opened new investigation
The most recent investigation began on February 19, 2026, after the Fala.BR system received a complaint related to possible bacterial contamination in Ypê dishwashing products and Tixan Neutralizes Odor laundry detergent.
According to information published by Folha, the complaint came from Unilever, a competitor of the Brazilian manufacturer and responsible for brands like Omo, Comfort, and Cif, after laboratory tests indicated the presence of the bacterium Pseudomonas aeruginosa.
Subsequently, Anvisa itself reported that analyses conducted by the manufacturer also identified the microorganism, an argument considered by the agency as one of the central factors to justify the adoption of precautionary measures applied against the unit.
Consumers who have the batches affected by the resolution were advised to immediately stop using the products and contact the company’s official service channels for information on exchange, return, reimbursement, and other planned procedures.
